Understanding the Pathophysiology of Equine Recurrent Uveitis

Equine Recurrent Uveitis (ERU), or moon blindness, is a destructive ocular condition affecting the middle layer of the eye. Unlike acute gastritis or systemic peritonitis which may have clear, singular triggers, ERU involves a complex interplay between the horse’s immune system and ocular antigens.

The Role of Leptospira interrogans

The most significant, well-documented trigger for ERU is infection by the bacteria Leptospira interrogans. Exposure to this pathogen, often through contaminated water or contact with infected wildlife, initiates an ocular inflammatory cascade. Even when the organism is cleared, the eye retains specific T-lymphocytes that remain "primed" to attack ocular tissues, creating a state of chronic autoimmunity.

Recognizing Clinical Signs and Emergency Indicators

Owners must be observant of subtle changes in ocular comfort, as ERU rarely presents as a quiet or indolent process. Early detection is critical to preventing permanent ocular damage.

Acute Phase Manifestations

  • Intense blepharospasm (squinting)

  • Significant epiphora (tearing)

  • Photophobia (aversion to light)

  • Miosis (constricted pupil)

  • Conjunctival hyperemia (redness)

Warning Signs of Progressive Damage

As the disease progresses, owners may note a cloudy or hazy appearance to the cornea, changes in the color of the iris (heterochromia), or the development of a 'star' pattern on the lens, indicating secondary cataract formation. If a horse suddenly refuses to be led into a dark trailer or avoids bright sunlight, they may be suffering from significant visual impairment due to chronic inflammation.

Diagnostic Approaches in Equine Ophthalmology

Veterinarians perform a comprehensive ophthalmic examination to assess both the anterior and posterior segments of the eye. A thorough evaluation includes the use of a slit-lamp biomicroscope, which allows for detailed visualization of the aqueous humor and internal structures. Measurement of intraocular pressure is essential to rule out secondary glaucoma, a painful complication of unchecked inflammation. In many cases, systemic testing for leptospirosis, including microscopic agglutination tests (MAT) on both serum and aqueous humor, is performed to confirm the etiology.

Therapeutic Management and Surgical Intervention

Management strategies focus on two goals: controlling active inflammation and preventing future flare-ups.

Medical Therapy

  • Topical corticosteroids: Used to suppress local inflammation.

  • Non-steroidal anti-inflammatories (NSAIDs): Systemic administration of flunixin meglumine is often required during acute crises.

  • Cycloplegic agents: Atropine is crucial to prevent the formation of synechiae, which can permanently fix the iris to the lens.

Surgical Procedures

In cases resistant to medical management, surgical options such as vitrectomy may be considered. During a vitrectomy, the inflamed vitreous humor is removed and replaced with a balanced salt solution, effectively removing the reservoir of inflammatory mediators and immune cells that drive the cycle of recurrence.

Long-Term Management and Preventive Strategies

Because ERU is chronic, it requires lifelong oversight. Owners should ensure their properties are protected from wildlife that may harbor leptospirosis and maintain strict hygiene around water sources. Horses with a history of ERU should be monitored daily for signs of squinting or ocular redness. Long-term use of low-dose, systemic NSAIDs may be necessary for some horses to stabilize the ocular environment.